MΒT-UTH: Metabolic Cost of Medicine Ball Training

Sponsor
University of Thessaly (Other)
Overall Status
Recruiting
CT.gov ID
NCT05412511
Collaborator
(none)
10
1
2
7
1.4

Study Details

Study Description

Brief Summary

In this study, the investigators will be able to estimate the metabolic cost of several foundational medicine ball training exercises.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MB-30
  • Behavioral: MB-45
N/A

Detailed Description

Medicine ball training has become a popular cardiovascular training choice in fitness centers and athletic performance enhancement facilities. Despite widespread use and growing popularity, little is known about the metabolic demands of such a training method. Therefore, the purpose of this study was to quantify the cardiovascular and metabolic cost from various foundational medicine ball exercises in order to contribute to a better planning of exercise programs in the real world.

Ten healthy young adults were assigned to execute seven bodyweight exercises (acute bout) for 30 and 45 seconds. Anthropometric, metabolic, functional capacity and performance measurements were conducted at baseline. The metabolic cost was estimated from heart rate, blood lactate, resting oxygen uptake, exercise oxygen uptake, and excess post-exercise oxygen consumption measurements using a portable gas analyzer.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Investigator)
Primary Purpose:
Other
Official Title:
Metabolic Cost of Medicine Ball Training
Actual Study Start Date :
May 1, 2022
Anticipated Primary Completion Date :
Sep 30, 2022
Anticipated Study Completion Date :
Nov 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training

Participants in this arm will perform six medicine ball training exercises (acute bout per exercise) at two different conditions (30 and 45 seconds).

Behavioral: MB-30
Medicine ball training exercises will be performed for 30 seconds and the training volume will be consisted of 1 repetition.

Behavioral: MB-45
Medicine ball training exercises will be performed for 45 seconds and the training volume will be consisted of 1 repetition.

No Intervention: Control

Participants in this arm will receive no intervention.

Outcome Measures

Primary Outcome Measures

  1. Change in exercise-induced energy expenditure [At pre-exercise, during, and 30 minutes after exercise session (single bout lasting 30 and 45 seconds]

    Exercise energy expenditure (kcal) will be measured using a portable indirect calorimetry system

  2. Change in excess post-exercise oxygen consumption (EPOC) [At 1 hour after exercise session (single bout lasting 30 and 45 seconds]

    EPOC (kcal) will be measured using a portable indirect calorimetry system

  3. Change in blood lactate concentration (BLa) [At pre-exercise and 3 minutes after exercise session]

    BLa (mmol/L) concentration will be measured in a microphotometer with commercially available kits.

  4. Change in heart rate [At pre-exercise, during, and 30 minutes after exercise session (single bout lasting 30 and 45 seconds]

    Heart rate (bpm) will be measured with a wearable heart rate monitor

  5. Change in perceived exertion [At pre-exercise, during, and 30 minutes after exercise session exercise session (single bout lasting 30 and 45 seconds]

    Rating of perceived exertion (RPE) will be measured with the Borg scale (0-10)

Secondary Outcome Measures

  1. Body weight [At baseline]

    Body weight will be measured on a beam balance with stadiometer

  2. Body height [At baseline]

    Body height will be measured on a beam balance with stadiometer

  3. Body mass index (BMI) [At baseline]

    BMI will be calculated using the Quetelet's equation

  4. Waist circumference (WC) [At baseline]

    WC (cm) will be measured using a Gullick II tape

  5. Hip circumference (HC) [At baseline]

    HC (cm) will be measured using a Gullick II tape

  6. Waist-to-hip ratio (WHR [At baseline]

    WHR will be calculated by dividing the waist by the hip measurement

  7. Resting metabolic rate (RMR) [At baseline]

    RMR (kcal) will be measured using a portable open-circuit indirect calorimeter with a ventilated hood system

  8. Body fat (BF) Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA) [At baseline]

    BF (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

  9. Fat mass (FM)t Body fat (%) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA) [At baseline]

    FM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

  10. Fat-free mass (FFM) [At baseline]

    FFM (kg) will be assessed by whole-body dual-energy X-ray absorptiometry (DXA)

  11. Maximal oxygen consumption (VO2max) [At baseline]

    VO2max (mL/kg/min) will be assessed by a portable open-circuit spirometry system

  12. Maximal strength (1RM) [At baseline]

    1RM (kg) will be measured bilaterally on a horizontal leg press and seated chest press machine.

  13. Muscular endurance [At baseline]

    Muscular endurance (repetitions) will be measured on a 1-min curl-up and push-up test.

  14. Functional capacity [At baseline]

    Functional capacity will be assessed using a movement-based screening tool titled Functional Movement Screening (FMS). The FMS will be consisted of 7 movement tasks that will be scored from 0 to 3 points and the sum will create score ranging from 0 to 21 points (0 = pain with pattern regardless of quality, 1 = unable to perform pattern, 2 = able to perform pattern with compensation/imperfection, 3 = able to perform pattern as directed)Functional capacity will be assessed using a movement-based screening tool titled Functional Movement Screening (FMS). The FMS will be consisted of 7 movement tasks that will be scored from 0 to 3 points and the sum will create score ranging from 0 to 21 points (0 = pain with pattern regardless of quality, 1 = unable to perform pattern, 2 = able to perform pattern with compensation/imperfection, 3 = able to perform pattern as directed)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Aged between 18 and 35 years

  • Physically active individuals

  • Free of chronic diseases

  • Free of musculoskeletal injuries

  • Nonsmokers

Exclusion Criteria:
  • Musculoskeletal injuries

  • Chronic diseases

  • Use of alcohol, caffeine and any type of ergogenic supplements or medication before (≤6 months) and throughout the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratory of Exercise Physiology, Exercise Biochemistry and Sports Nutrition, School of Physical Education, Sports Sciences and Dietetics, University of Thessaly Trikala Greece 42100

Sponsors and Collaborators

  • University of Thessaly

Investigators

  • Study Director: Ioannis G Fatouros, Prof, University of Thessaly

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ioannis G. Fatouros, Professor, University of Thessaly
ClinicalTrials.gov Identifier:
NCT05412511
Other Study ID Numbers:
  • MΒT-UTH
First Posted:
Jun 9, 2022
Last Update Posted:
Jun 9, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ioannis G. Fatouros, Professor, University of Thessaly

Study Results

No Results Posted as of Jun 9, 2022